An overview of the design and rationale for the phase 2 BRIDGET study looking at the addition of tucatinib to HER2-directed antibody therapy in breast cancer.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
76 Electromagnetic Chip Bracketed vs Wire Bracketed Localization in Breast Conserving Surgery